Product
Supplier
Encyclopedia
Inquiry
TR20 Tirzepatide 20mg/vial buy - large image1
TR20 Tirzepatide 20mg/vial buy - image1
TR20 Tirzepatide 20mg/vial buy - image2
TR20 Tirzepatide 20mg/vial buy - image3
TR20 Tirzepatide 20mg/vial buy - image4

TR20 Tirzepatide 20mg/vial

TDS 2068 Inquiries

Unit Price:

$68/G FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SHENGZHEN

Brand:

KSD

Packaging:

20mg/box

Price valid (until):

2026-09-05

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Contact Us 


    • Name:Chloe
    • WeChat and WhatApps:+852 6732 2979
    • Emails:3524465053@qq.com
    • Product Description:

    • TR20 (Tirzepatide) Lyophilized Research Peptide Powder
      Specification: 20 mg per vial, 10 vials per kit
      Appearance: White to off‑white lyophilized cake / powder in clear glass vial
      Solubility: Freely soluble in sterile water for reconstitution. Reconstituted solution should be clear and colourless, free of cloudiness, particles or sediment.

      TR20 (Tirzepatide, LY‑3298176) is a synthetic 39‑amino‑acid dual GIP / GLP‑1 receptor agonist peptide for laboratory research work only.
      Storage: Store sealed at -20℃, keep away from light and avoid repeated freeze‑thaw cycles.

    • Shop TR20 Tirzepatide 20mg/vial-Detailed Image 1

    Items Specifications
    Product Name RT20 (Retatrutide)
    Molecular Weight ~4754.35
    Appearance White to off‑white lyophilized cake/powder
    Solubility Freely soluble in sterile water, clear colourless solution after reconstitution
    Purity ≥99.0%
    Storage Condition Sealed at -20℃, protected from light, avoid repeated freeze‑thaw


    Safety & Potential Risks 


    • TR20 (Tirzepatide) is intended for laboratory research purposes only. It is not manufactured for human injection, clinical treatment or animal administration.
      Direct physical contact with the lyophilized powder may lead to mild irritation to skin and mucous membranes. Avoid touching eyes, nose and open wounds. In case of accidental contact, rinse affected area with plenty of clean water. Wear appropriate protective nitrile gloves when handling vials and powder. Do not inhale dry peptide dust; work in a well‑ventilated operating environment.
      Keep this product completely separated from food, drinking water and consumables. Do not eat, drink or smoke while handling the material.

      After reconstitution, inspect the solution carefully. If the liquid turns cloudy, milky, or contains floating particles or sediment, the product should be discarded and must not be used for any test work.
      Seal the vials tightly during storage. Keep out of access of untrained staff and irrelevant persons. Do not transfer to unmarked containers.

      Any residual peptide solution, empty vials and contaminated waste should be treated as chemical laboratory waste and disposed of in compliance with local environmental and chemical waste regulations.

      Improper storage, repeated freeze‑thaw cycles or high‑temperature exposure may degrade peptide quality and cause abnormal solution performance.


      Product Images


    Shop TR20 Tirzepatide 20mg/vial-Detailed Image 2



       About KSD 


    Shop TR20 Tirzepatide 20mg/vial-Detailed Image 3


    FAQ 


    1. Q: What are your production cycle and delivery time?
    A: For regular in-stock peptide products, the production cycle is 3 to 7 working days. We ship entirely by air, with a total transportation cycle of 10 to 14 working days after delivery. Ample stock ensures a long-term, stable, and uninterrupted supply.

    2. Q: What are your main export markets?

    A: Our products are sold worldwide, including the United States, Canada, Australia, the Netherlands, New Zealand, Italy, France, Germany, Mexico, and many other countries and regions.

    3. Q: What customer service and after-sales support do you provide?
    A: We provide comprehensive customer service throughout the entire process. If you encounter problems with product quality, air freight damage, shipping documents, or product usage guidelines, our team will respond quickly and provide practical solutions to fully protect your legal rights.

    4. Q: How is the quality of your products?

    A: Each batch of products undergoes rigorous quality inspection before delivery to ensure HPLC purity is above 99%. Complete inspection documents, such as product certificates and HPLC reports, will be provided for your reference.

    5. Q: What shipping methods do you use?

    A: We use professional air freight for all peptide shipments, combined with cold chain packaging, to ensure the activity and stability of the peptides during transportation.

    6. Q: What payment methods are available for orders?

    A: We support Alipay, Bitcoin, and USDT for your selection.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide

    Location:

    Licheng District, Jinan City, Shandong Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

    Certifications:

    Retatrutide coa

    Hello and welcome to learn about Kangshengda Biotechnology! We are a specialized enterprise dedicated to the R&D and production of peptide products. Leveraging high-quality peptide preparations, our core strength lies in supporting customers to achieve long-term weight management and all-round health regulation.
    Boasting extensive mature export experience, our products are sold to Europe, the United States and numerous other countries and regions worldwide. Supported by consistent, reliable product quality, efficient on-time delivery and a comprehensive professional after-sales service system, we have built long-term, solid strategic partnerships with overseas distributors.
    We are committed to delivering one-stop customized premium peptide solutions for all clients, and seek long-term development and win-win cooperation alongside domestic and global partners!
    KSD
    ">KSD
  • Inquiry History
    2068 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.